**Core Concept**
Sickle cell anemia is a genetic disorder affecting **hemoglobin** production, leading to abnormal red blood cells. It is characterized by a mutation in the **HBB** gene, which codes for the beta-globin subunit of hemoglobin. This results in **sickle hemoglobin** (HbS) production.

**Why the Correct Answer is Right**
The correct answer is not provided, but sickle cell anemia is typically described as an autosomal recessive disorder. The mutation leads to the production of HbS, which causes red blood cells to assume a **sickle shape** under low oxygen conditions. This shape interferes with normal blood flow, leading to various clinical manifestations.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the correct answer provided, it's challenging to assess each option directly. However, common incorrect descriptions of sickle cell anemia might include it being an autosomal dominant disorder or a condition affecting a different aspect of hemoglobin production.
**Option B:** Similarly, without the correct answer, it's difficult to pinpoint why this option is incorrect, but it might misdescribe the genetic basis or the clinical presentation of the disease.
**Option C:** This option could potentially mischaracterize the disorder's inheritance pattern or its effects on red blood cells.
**Option D:** Without knowing the specific text of each option, it's hard to say, but a common mistake might be describing sickle cell anemia as a disorder that affects a different component of the blood or has a different underlying cause.

**Clinical Pearl / High-Yield Fact**
A key point to remember about sickle cell anemia is that it is caused by a **point mutation** in the **HBB** gene, leading to the substitution of valine for glutamic acid at position 6 of the beta-globin chain. This single change has profound effects on the structure and function of hemoglobin.

**Correct Answer:** Not provided in the query.